21.2 Percent of U.S. Adults Had Diagnosed Arthritis From 2019 to 2021
Medically reviewed by Drugs.com.
By Elana Gotkine HealthDay Reporter
THURSDAY, Oct. 12, 2023 -- An estimated 21.2 percent of U.S. adults had diagnosed arthritis from 2019 to 2021, with most cases among adults aged 45 years and older, according to research published in the Oct. 13 issue of the U.S. Centers for Disease Control and Prevention Morbidity and Mortality Weekly Report.
Elizabeth A. Fallon, Ph.D., from the CDC in Atlanta, and colleagues updated national prevalence estimates of self-reported diagnosed arthritis by analyzing combined 2019 to 2021 National Health Interview Survey data.
The researchers found that during this time frame, an estimated 21.2 percent of U.S. adults aged 18 years and older had diagnosed arthritis. The age-standardized prevalence rates were higher among women than men (20.9 versus 16.3 percent), among veterans than nonveterans (24.2 versus 18.5 percent), and among non-Hispanic White versus Hispanic or Latino and non-Hispanic Asian adults (20.1 percent versus 14.7 and 10.3 percent, respectively). Of all U.S. adults with arthritis, 88.3 percent were adults aged 45 years and older. The unadjusted arthritis prevalence was high among adults with chronic obstructive pulmonary disease (COPD), dementia, disability, stroke, heart disease, diabetes, or cancer (57.6, 55.9, 54.8, 52.6, 51.5, 43.1, and 43.1 percent, respectively). Among adults aged 65 years and older with COPD, dementia, stroke, heart disease, diabetes, or cancer, about one-half also had a diagnosis of arthritis.
"These estimates can be used to guide public health activities, policies, and resource allocation for improving arthritis-attributable health outcomes and associated health care costs," the authors write.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2024 HealthDay. All rights reserved.
Posted October 2023
Read this next
AI-Assisted Contours Superior to Cognitively Defined Prostate Cancer Contours
WEDNESDAY, July 3, 2024 -- Artificial intelligence (AI)-assisted definition of prostate cancer contours reduces underestimation of the extent of prostate cancer, according to a...
Mean Cost of Bringing New Drug to U.S. Market Is $879.3 Million
TUESDAY, July 2, 2024 -- The mean cost of developing a new drug for the U.S. market is estimated to be $879.3 million when both drug development failure and capital costs are...
Patient–Primary Care Provider Language Concordance Tied to Better Outcomes
TUESDAY, July 2, 2024 -- Patient-family physician language concordance is associated with a lower risk for adverse outcomes, according to a study published online June 3...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.